April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Toll-like Receptor Mediated Induction of TSLP and IL-33 by Murine Dendritic Cells in Response to Microbial Ligands
Author Affiliations & Notes
  • Zhitao Su
    Ocular Surface Center, Cullen Eye Institute, Department of Ophthalmology, Baylor College of Medicine, Houston, Texas
    School of Optometry and Ophthalmology, Wenzhou Medical College, Wenzhou, China
  • Lili Zhang
    Ocular Surface Center, Cullen Eye Institute, Department of Ophthalmology, Baylor College of Medicine, Houston, Texas
    Ophthalmology, the Affiliated Hospital of Qingdao University Medical College, Qingdao, China
  • Stephen C Pflugfelder
    Ocular Surface Center, Cullen Eye Institute, Department of Ophthalmology, Baylor College of Medicine, Houston, Texas
  • De-quan Li
    Ocular Surface Center, Cullen Eye Institute, Department of Ophthalmology, Baylor College of Medicine, Houston, Texas
  • Footnotes
    Commercial Relationships  Zhitao Su, None; Lili Zhang, None; Stephen C Pflugfelder, None; De-quan Li, None
  • Footnotes
    Support  DOD CDMRP PRMRP Grant FY06 PR064719 (DQL), NIH Grant EY11915 (SCP), Research to Prevent Blindness, Oshman Foundation, William Stamps Farish Fund.
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 2908. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Zhitao Su, Lili Zhang, Stephen C Pflugfelder, De-quan Li; Toll-like Receptor Mediated Induction of TSLP and IL-33 by Murine Dendritic Cells in Response to Microbial Ligands. Invest. Ophthalmol. Vis. Sci. 2011;52(14):2908.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Thymic stromal lymphopoietin (TSLP) and Interleukin (IL) 33 have been identified as two novel pro-allergic cytokines that initiate Th2-dominant allergic inflammation. This study was to explore the toll-like receptor (TLR) mediated induction of TSLP and IL-33 by murine dendritic cells (DCs) in response to microbial ligands.

Methods: : Bone marrow cells were isolated from femur bone of BALB/c mouse, and cultured in RPMI1640 medium supplemented with 10% FBS, 20 ng/ml rmGM-CSF and 5 ng/ml rmIL-4 for 8-10 days. The induced immature DCs (iDCs) were treated with 9 microbial components (10µg/ml, each), ligands to TLRs 1-9, for 4-24 hours. The mRNA expression was determined by reverse transcription (RT) and real time PCR. The protein production was measured by ELISA or Western blot.

Results: : All TLRs 1-9 studied were found to be expressed by murine DCs as determined by RT and real-time PCR. Comparison of their mRNA levels showed that TLR2 and TLR7 were the most abundantly expressed, while TLR4 had the lowest expression. The induction of TSLP and IL-33 mRNA was found to reach peak levels at 4 hour fllowing TLR ligand stimulation. The mRNA expression of TSLP and IL-33 was markedly stimulated by multiple microbial components including Pam3csk4, poly I:C (dsRNA), LPS, flagellin and FSL-1, ligands for TLRs 1 and 3-6, respectively. Among them, LPS displayed the strongest stimulation of TSLP (13.6±7.8 fold) and IL-33 (12.7±5.1 fold). Interestingly, the expression of CD80 and CD86, markers for mature DCs, was also significantly induced by these TLR ligands with highest levels by LPS. This pattern of TSLP and IL-33 induction was confirmed at protein levels.

Conclusions: : Our findings demonstrate that murine DCs express at least TLRs 1-9, and the pro-allergic cytokines TSLP and IL-33, which was induced through TLR-mediated pathway in response to microbial components, especially to ligands of TLRs 1 and 3-6. It suggests an important role of DCs in pathogenesis of allergic inflammation.

Keywords: inflammation • immunomodulation/immunoregulation • cytokines/chemokines 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×